Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy.
about
Recent advances in understanding Type 1 DiabetesDevelopment and Function of Protective and Pathologic Memory CD4 T CellsT cell epitopes and post-translationally modified epitopes in type 1 diabetesMajor Histocompatibility Complex Class II Dextramers: New Tools for the Detection of antigen-Specific, CD4 T Cells in Basic and Clinical ResearchInherent low Erk and p38 activity reduce Fas Ligand expression and degranulation in T helper 17 cells leading to activation induced cell death resistanceImmune recognition of citrullinated epitopes.Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis.MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritisInsights from populations at risk for the future development of classified rheumatoid arthritisQuantitative and qualitative characterization of expanded CD4+ T cell clones in rheumatoid arthritis patients.Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis.Citrullination only infrequently impacts peptide binding to HLA class II MHCAssociation of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery AtherosclerosisGeneration mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritisImmune cell profiling to guide therapeutic decisions in rheumatic diseasesEfficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining.Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis.Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.B cells and their cytokine activities implications in human diseases.Mechanisms involved in triggering rheumatoid arthritis.Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis.The role of autoantibodies in the pathophysiology of rheumatoid arthritisThe immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.HLA class II and rheumatoid arthritis: the bumpy road of revelation.Antigen-specific immunotherapies in rheumatic diseases.Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance.Targeting of tolerogenic dendritic cells towards heat shock proteins: a novel therapeutic strategy for autoimmune diseases?Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid ArthritisCrystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritisSynovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis.Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens.The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.Synovial tissue macrophages: friend or foe?Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol Development.The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in Rheumatoid Arthritis.Citrullinated α-enolase is an effective target for anti-cancer immunity.Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
P2860
Q26766139-691590FF-B4C8-4642-9725-F12F341BC880Q26781324-4704D3A4-27CD-42EB-A9A6-BF8C0E97B324Q26787014-497F7F04-00C1-4F87-AE30-F7F29927E9C9Q26799836-61910E94-6A6D-491C-9637-AE117F13E0D8Q28277617-9A9F7E3E-40A0-467E-ABD8-34443DBE1899Q30391892-0F760160-6F4B-44BD-90FC-D8D639DC25D9Q33822112-6CF3608C-4835-467E-B7C8-26C97E8AF11FQ33849824-A07C6549-D2E5-4BF9-8996-F4D7472A2F0DQ34604615-A2441570-B905-46FD-A727-2D41B4BAE333Q35974666-1ADD14FA-5E92-45BF-8B66-F173175D0D41Q36090224-CED7C101-F79F-44B1-98CD-BC19A270F24AQ36365784-2F509EE6-307A-4B90-BC46-7B7A689862CDQ36403294-1940C637-C158-4197-8B69-F048E48C117FQ36691934-3915EB18-CE01-4727-97CF-D16921471767Q36982828-F17BD5CA-126A-48E3-AA6A-C2A8113A7EF7Q37237425-217D3F63-C250-4883-8C54-A81131E9CE6EQ38474636-42FCDE68-BF71-4086-8044-97DF39069F1CQ38489669-D1455C3A-077B-443D-BA56-AFD097D23BB8Q38665740-457EF39D-3260-4308-B7F3-FF5091A1D68AQ38673425-362DEC5E-6F96-40C6-B086-7B01B9A93DD8Q38682156-CEA754CB-ED8F-4987-8CDE-0DD98C389F30Q38758623-D196FDCB-4D75-41F8-8DC1-F4A704C5732CQ38815526-973BB5FB-D892-4718-91E4-7A8C627F9363Q39029106-FEE75678-371C-4590-9E8F-85D70F916FC0Q39427587-7894E93C-0B7C-4BF1-BE74-14D11C632403Q39431371-E02DA269-C32C-4473-A4B6-C5E30A766471Q39770778-0AC05241-39D1-421E-9D6A-CCA85A6E013AQ40095092-A5805EB9-1F11-42F3-AC8D-BBED63DCBB85Q40432151-D0E8188B-50B6-49AC-BD33-F6572BD3DB60Q40697747-1E32A144-24C1-4FA5-8581-D986C184A1B9Q40891825-E4D3420E-1EC8-4E00-9315-EDD3426728B5Q40961898-57C54860-08E1-4AB8-9B49-6A17D40ECE73Q41661241-1162654C-B939-4F08-BF7A-8AF6252844B8Q42135457-D10614C4-1B61-4DFA-B045-A7F8C56504E6Q47189951-2FA47549-6E0A-481E-9999-CB535AF968DFQ47212014-9FC59829-9921-4650-980A-D542C34C1756Q49594014-667482D7-F1E3-410B-AA40-11101AE742A3Q50113126-5DDA1F50-5A14-46E3-B348-18C42ABE7E22Q50545407-975633CE-A392-42AD-97E3-DFAF1DECD7C8Q52595625-2617F0CA-2348-4D07-90B5-D852E17339FA
P2860
Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Citrulline-specific Th1 cells ...... disease duration and therapy.
@en
Citrulline-specific Th1 cells ...... disease duration and therapy.
@nl
type
label
Citrulline-specific Th1 cells ...... disease duration and therapy.
@en
Citrulline-specific Th1 cells ...... disease duration and therapy.
@nl
prefLabel
Citrulline-specific Th1 cells ...... disease duration and therapy.
@en
Citrulline-specific Th1 cells ...... disease duration and therapy.
@nl
P2093
P2860
P50
P356
P1476
Citrulline-specific Th1 cells ...... disease duration and therapy.
@en
P2093
Betty B Yue
Charlotta Sandin
Jane H Buckner
Jennifer Pieper
John A Gebe
Mary Rieck
Megan Tatum
Melissa Peda
P2860
P304
P356
10.1002/ART.38637
P577
2014-07-01T00:00:00Z